PPAR-γ Agonist Alleviates Liver and Spleen Pathology via Inducing Treg Cells during Schistosoma japonicum Infection

Figure 2

The expression of regulatory cells and effector Th1/Th2 cells after pioglitazone treatment of S. japonicum infection. (a–d) Single cell suspensions of mouse spleen or liver from pioglitazone-treated mice infected with or without S. japonicum were prepared. (a) The absolute numbers of CD4⁺ T cells both in the liver and spleen of mice were calculated as the proportion of CD3⁺CD4⁺ T cells in the leukocyte gate multiplied by the total cell count. (b) Cells were stained with CD25-APC and CD4-FITC and then intracellularly stained with PE-conjugated antibodies against Foxp3 for FACS analysis of CD4⁺CD25⁺Foxp3⁺ (Treg). (c, d) Cells were stained with CD3-APC and CD4-FITC and then intracellularly stained with PE-conjugated antibodies against IFN-γ or IL-4 for FACS analysis of CD3⁺CD4⁺IFN-γ⁺ (Th1) or CD3⁺CD4⁺IL-4⁺ (Th2) cells, respectively. Data are expressed as the mean ± SD of 12 mice for each group from three independent experiments (ANOVA/LSD), , , and .

(a)

(b)

(c)

(d)